Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment

Maria Marchante, Ferran Barrachina, Sabrina Piechota, Marta Fernandez-González, Alexa Giovannini, Trozalla Smith, Simone Kats, Bruna Paulsen, Eva González, Virginia Calvente, Ana Silvan, Baruch Abittan, Joshua Klein, Peter Klatsky, Daniel Ordonez, Christian C. Kramme
doi: https://doi.org/10.1101/2024.03.28.24304995
Maria Marchante
1Gameto Inc., New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferran Barrachina
1Gameto Inc., New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina Piechota
1Gameto Inc., New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Fernandez-González
1Gameto Inc., New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexa Giovannini
1Gameto Inc., New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trozalla Smith
2Spring Fertility, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Kats
1Gameto Inc., New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruna Paulsen
1Gameto Inc., New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva González
3Ruber Juan Bravo University Hospital, Eugin Group, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia Calvente
3Ruber Juan Bravo University Hospital, Eugin Group, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Silvan
3Ruber Juan Bravo University Hospital, Eugin Group, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baruch Abittan
4Extend Fertility, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua Klein
4Extend Fertility, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Klatsky
2Spring Fertility, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Ordonez
3Ruber Juan Bravo University Hospital, Eugin Group, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian C. Kramme
1Gameto Inc., New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: christian{at}gametogen.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

Data Sharing Statement: All data needed to evaluate the conclusions in the paper are present in the paper and supplementary tables and figures.

Back to top
PreviousNext
Posted March 28, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment
Maria Marchante, Ferran Barrachina, Sabrina Piechota, Marta Fernandez-González, Alexa Giovannini, Trozalla Smith, Simone Kats, Bruna Paulsen, Eva González, Virginia Calvente, Ana Silvan, Baruch Abittan, Joshua Klein, Peter Klatsky, Daniel Ordonez, Christian C. Kramme
medRxiv 2024.03.28.24304995; doi: https://doi.org/10.1101/2024.03.28.24304995
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment
Maria Marchante, Ferran Barrachina, Sabrina Piechota, Marta Fernandez-González, Alexa Giovannini, Trozalla Smith, Simone Kats, Bruna Paulsen, Eva González, Virginia Calvente, Ana Silvan, Baruch Abittan, Joshua Klein, Peter Klatsky, Daniel Ordonez, Christian C. Kramme
medRxiv 2024.03.28.24304995; doi: https://doi.org/10.1101/2024.03.28.24304995

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Obstetrics and Gynecology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)